The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial

Dogar O, Barua D, Böckmann M, Elsey H, Fatima R, Gabe R, Huque R, Keding A, Khan A, Kotz D, Kralikova E, et al. (2018)
Addiction 113(9): 1716-1726.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Dogar, Omara; Barua, Deepa; Böckmann, MelanieUniBi ; Elsey, Helen; Fatima, Razia; Gabe, Rhian; Huque, Rumana; Keding, Ada; Khan, Amina; Kotz, Daniel; Kralikova, Eva; Newell, James N.
Alle
Alternativer Titel
TB and Tobacco trial
Erscheinungsjahr
2018
Zeitschriftentitel
Addiction
Band
113
Ausgabe
9
Seite(n)
1716-1726
ISSN
0965-2140
Page URI
https://pub.uni-bielefeld.de/record/2943862

Zitieren

Dogar O, Barua D, Böckmann M, et al. The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial. Addiction. 2018;113(9):1716-1726.
Dogar, O., Barua, D., Böckmann, M., Elsey, H., Fatima, R., Gabe, R., Huque, R., et al. (2018). The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial. Addiction, 113(9), 1716-1726. doi:10.1111/add.14242
Dogar, O., Barua, D., Böckmann, M., Elsey, H., Fatima, R., Gabe, R., Huque, R., Keding, A., Khan, A., Kotz, D., et al. (2018). The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial. Addiction 113, 1716-1726.
Dogar, O., et al., 2018. The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial. Addiction, 113(9), p 1716-1726.
O. Dogar, et al., “The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial”, Addiction, vol. 113, 2018, pp. 1716-1726.
Dogar, O., Barua, D., Böckmann, M., Elsey, H., Fatima, R., Gabe, R., Huque, R., Keding, A., Khan, A., Kotz, D., Kralikova, E., Newell, J.N., Nohavova, I., Parrott, S., Readshaw, A., Renwick, L., Sheikh, A., Siddiqi, K.: The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial. Addiction. 113, 1716-1726 (2018).
Dogar, Omara, Barua, Deepa, Böckmann, Melanie, Elsey, Helen, Fatima, Razia, Gabe, Rhian, Huque, Rumana, Keding, Ada, Khan, Amina, Kotz, Daniel, Kralikova, Eva, Newell, James N., Nohavova, Iveta, Parrott, Steve, Readshaw, Anne, Renwick, Lottie, Sheikh, Aziz, and Siddiqi, Kamran. “The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial”. Addiction 113.9 (2018): 1716-1726.

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 29676824
PubMed | Europe PMC

Suchen in

Google Scholar